Fertility treatments could be a factor that will result in declining fecundity (potential for fertility, such as regular menstrual cycles) across the generations, some researchers say. Others point to the depression that can come with infertility as a reason to offer medicalized pregnanies. Image
Last week President Obama lifted restrictions on federal funding for embryonic stem cell research and asked the National Institutes of Health to come up with a funding game plan within 120 days. Yet while the field of stem cell research holds great promise, hype and misconceptions cloud the picture. Here are a five such misconceptions.
1. George W. Bush killed research on embryonic stem cells.
Wrong. Bush actually was the first president to allow federal funding. Bill Clinton had chickened out. A very brief history follows.
In 1974, Congress banned federal funding on fetal tissue research and established the Ethics Advisory Board to study the nascent field of in vitro fertilization. In 1980 Ronald Reagan killed the Board, which was friendly to embryonic research, resulting in a de facto moratorium on funding. Congress tried to override the moratorium in 1992, but George H.W. Bush vetoed it. Bill Clinton lifted the moratorium in 1993 but reversed his decision in 1994 after public outcry. In 1995, Congress passed the Dickey-Wicker Amendment, banning federal funding on any research that destroys human embryos.
In 2001 Bush enabled limited funding on embryonic stem cell lines already derived from discarded embryos; the life or death decision already had been made, he said. He thought more than 60 lines existed, but within months scientists realized that only about 20 were viable, not enough to do substantial research.
2. Bush spurred development of alternative sources of embryonic stem cells.
Sure, in the same way his disastrous invasion of Afghanistan and Iraq spurred the development of treatment for massive head trauma, or the way his economic policies have encouraged all of us to do more with less. One doesn't advance a scientific field by handicapping researchers.
Regardless, the biggest advance in recent years has come from Japan by a researcher not affected by U.S. research funding rules. U.S. federal funding could have led to even more advances of alternative sources, because funding stem cell research in general can have a synergetic effect across the various research specialties.
3. Embryonic stem cells are no longer needed.
Wrong. In 2007, Shinya Yamanaka of Kyoto University in Japan announced a breakthrough in which adult skin cells could be coaxed back into an embryonic state and thus regain the ability to branch into any kind of human cell, such as heart, pancreas or spinal cord nerve cell. While a major advance, the work itself is in an embryonic state, years from practical application.
The work on these so-called induced pluripotent stem (iPS) cells complements embryonic stem cell research; it doesn't replace it. The iPS cells have a greater tendency to become cancerous. Work on "real" embryonic stem cells is needed, at a minimum, to understand what iPS cells lack. Many view Yamanaka's technique as brilliant yet worry that his four-gene manipulation of adult cells might be too simplistic.
Research on iPS cells is particularly exciting because it opens the possibility of using one's own cells say, from skin to produce pancreas cells to cure diabetes, whereas embryonic stem cells would introduce DNA from a stranger.
4. Cures are around the corner.
Wrong. Stem cell research is dominated by hype. Remember gene therapy, the insertion of genes into human cells to cure all types of diseases? Nearly two decades after the first gene therapy procedure, the technique remains highly experimental and problematic. Stem cell research faces a similar future.
5. Obama's executive order means "all systems go."
Unlikely. The new rule eliminates red tape, for now researchers can study any established embryonic stem cell line. Previously, stem cell researchers receiving private and public funding needed to keep detailed records of spending, down to which microscope is used for which kind of stem cell. That's history.
But the Dickey-Wicker Amendment (see No. 1 above) is the law of the land, meaning federally funded researchers cannot create new embryonic stem cells lines. They can work only on those new lines created with private funding, which aren't that plentiful. Also, some scientists worry that crucial private funding will dry up with the poor economy and false reassurances that federal funding is in place.
The furor over stem cells focuses on the definition of human life, which many believe begins when sperm meets eggs. Yet inevitably lines will be blurred in coming years when babies are born with the DNA of two sperms or ova transplanted into an egg. Just as humans evolved from non-humans with no precise generation in which a non-human gave birth to a human we may come to understand that all of nature is a continuum.
Christopher Wanjek is the author of the books "Bad Medicine" and "Food At Work." His column, Bad Medicine, appears each Tuesday on LiveScience.
The rest is here:
Embryonic Stem Cells: 5 Misconceptions - livescience.com
- Identifying the best reagent to transfect human embryonic stems cells - News-Medical.net - December 11th, 2019
- Pig-Monkey Chimeras Have Been Brought to Term For The First Time - ScienceAlert - December 11th, 2019
- First Pig-Monkey Chimeras Were Just Created in China - Livescience.com - December 11th, 2019
- PHATED to be: Yale researchers give shape to big data - Yale News - December 11th, 2019
- Cell Harvesting Market a compound annual growth rate (CAGR) of 11.3% for the period of 2018-2023 - Crypto News Byte - December 11th, 2019
- Modulating the expression and activity of the potassium-chloride cotransporter KCC2 - SFARI News - November 26th, 2019
- Stem cells' role in medicine and research - The Medium - November 26th, 2019
- Stem Cell Assay Market Demand with Leading Key Players and New Investment Opportunities Emerge To Augment Segments in Sector By 2025 - The Denton... - November 26th, 2019
- Human Embryonic Stem Cells (HESC) Market with Future Prospects, Key Player SWOT Analysis and Forecast To 2024 - Chronicles 360 - November 22nd, 2019
- Growing Organs in the Lab: One Step Closer to Reality - BioSpace - November 21st, 2019
- Major step taken in creating complex organs in the lab - Drug Target Review - November 21st, 2019
- Cell Therapy Aims To Improve Memory and Prevent Seizures Following Traumatic Brain Injury - Technology Networks - November 21st, 2019
- WCM-Q explores law and ethics of stem cells and AI in medicine - The Peninsula Qatar - November 18th, 2019
- Qatar- WCM-Q explores law and ethics of stem cells and AI in medicine - MENAFN.COM - November 18th, 2019
- New cell therapy improves memory and stops seizures after brain injury - Drug Target Review - November 18th, 2019
- Stem Cell Therapy Market by Treatment,Application,End Users and Geography Forecast To 2026 - Markets Gazette 24 - November 11th, 2019
- Global Stem Cell Assay Market 2019 Size, Share, Growth, Trends, Type, Application, Analysis and Forecast by 2026 - Markets Gazette 24 - November 11th, 2019
- Oct4, Considered Vital for Creating iPSCs, Actually Isnt Needed - The Scientist - November 8th, 2019
- A winding romp through advances in cell biology pushes readers to ponder the boundaries of life - Science Magazine - October 31st, 2019
- Cell Banking Outsourcing Market to 2027 - Global Analysis and Forecasts By Product Type (Cord Cell Banking, Adult Stem Cell Banking, Embryonic Stem... - October 31st, 2019
- Cell Isolation Market ||Becton, Dickinson, and Company, Thermo Fisher Scientific, Inc., Merck KGaA - Industry News Info - October 31st, 2019
- Scientists Made Mice Live 12% Longer by Hacking Their Telomeres - Futurism - October 22nd, 2019
- Scientists extend mice lifespan 12% by tweaking telomeres - Big Think - October 22nd, 2019
- Merck KGaA opens Shanghai Innovation Center and invests $ 14 million in the China Seed Fund - asume tech - October 19th, 2019
- Health policy will be the focus of the HLTH - asume tech - October 19th, 2019
- Syros sees strategic shift after the failure of the previously promising cancer drug - asume tech - October 19th, 2019
- What Theranos Whistleblowers Learn About Ethics in Health Startups - asume tech - October 19th, 2019
- Assessments of Treatment Options for Age-related Macular Degeneration - DocWire News - October 15th, 2019
- Stem Cells Market Growth Rate, Production Volume and Future Opportunities From 2019-2024 - Exponent Online - October 15th, 2019
- Catholics more motivated to donate if ethical investing is assured - Crux: Covering all things Catholic - October 10th, 2019
- Greenwood to step down as CEO of BIO after 2020 election - FierceBiotech - October 10th, 2019
- Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1 - Science Advances - October 10th, 2019
- Interview with Tamer Mohamed of Aspect Biosystems on Advancing Tissue Therapeutics - 3DPrint.com - October 10th, 2019
- Yale researchers develop way to help brain organoids thrive - Yale News - October 9th, 2019
- Catholics more motivated to donate if ethical investing is assured - The Catholic Spirit - October 9th, 2019
- Stem Cell Market: By Key Players, Market Competitive Landscape, Trends and Forecasts to 2024 - Joliet Observer - October 9th, 2019
- Stem Cell Therapy Market to Witness a Pronounce Growth During 2020 - Gem Newz - October 9th, 2019
- On creativity, plasticity and repentance - Arutz Sheva - October 5th, 2019
- What's in the cards for this year's Nobel Prizes? - STAT - October 2nd, 2019
- Moving beyond hype: Could one-two treatment restore damaged heart muscle? - University of Wisconsin-Madison - September 28th, 2019
- Conjugated polymers optically regulate the fate of endothelial colony-forming cells - Science Advances - September 28th, 2019
- God of miniscule things - Pune Mirror - September 27th, 2019
- New study shows insight into how cells maintain their identity - Drug Target Review - September 24th, 2019
- Human Embryonic Stem Cells Market: Expansion Strategies Set to Generate Substantial Revenue in the near Future - Rapid News Network - September 24th, 2019
- Global Stem Cells Market 2019 Strategic Assessment by Top Players CCBC, Vcanbio, Boyalife, Beikebiotech - News Coed - September 24th, 2019
- Study Gives Clues to the Origin of Huntington's Disease, and a New Way to Find Drugs - Nature World News - September 24th, 2019
- Global Stem Cells Market 2019 Business Statistics Focus Report Growth by Top Key Players CCBC, Vcanbio, Boyalife, Beikebiotec - The Industry News... - September 24th, 2019
- Orthopedic Biomaterials Product Market Set to Witness YoY Growth by 2018-2026 - NewsStoner - September 24th, 2019
- Global Fetal Bovine Serum Market : Industry Analysis and Forecast (2017-2026) - OnYourDesks - September 24th, 2019
- Stem Cell Therapy Market to Discern Steadfast Expansion During 2020 - Technology Trend - September 24th, 2019
- Embryonic Stem Cell - an overview | ScienceDirect Topics - May 22nd, 2019
- Embryonic Stem Cell Research and Vaccines using Fetal Tissue - May 6th, 2019
- Embryonic Stem Cells - Definitions, Use, and Research - April 28th, 2019
- Will Embryonic Stem Cells Ever Cure Anything? - MIT ... - April 28th, 2019
- Creating Embryonic Stem Cells Without Embryo Destruction - April 23rd, 2019
- What Are Stem Cells? - livescience.com - April 19th, 2019
- Embryonic Stem-Cell Research Reaches Moral, Medical Dead End - April 8th, 2019
- Embryonic Stem Cell: Definition, Uses and Collection ... - April 2nd, 2019
- Advantages of Embryonic Stem Cell Research | Sciencing - March 30th, 2019
- Practical Problems with Embryonic Stem Cells - usccb.org - March 20th, 2019
- Obama Ends Stem Cell Research Ban - CBS News - March 10th, 2019
- Types of Stem Cells A Closer Look at Stem Cells - January 26th, 2019
- Embryonic Stem Cell Research - rtlofneo.com - December 19th, 2018
- The Ethics Of Embryonic Stem Cell Research Viewpoint Essay - December 11th, 2018
- Embryonic Stem Cells and Artificial Stem Cells Are ... - December 5th, 2018
- Embryonic stem cells | Cells | MCAT | Khan Academy - November 25th, 2018
- Crucial Differences Between Non-Embryonic and Embryonic Stem ... - November 23rd, 2018
- 14 Key Pros and Cons of Embryonic Stem Cell Research ... - November 5th, 2018
- Human Embryonic Stem Cells in Development, Volume 129 ... - September 29th, 2018
- Reprogrammed stem cells identical to embryonic stem cells - September 29th, 2018
- Embryonic Stem Cell Protocols by Kursad Turksen | Waterstones - September 29th, 2018
- What Are Stem Cells? Research, Transplant, Therapy, Definition - July 17th, 2018
- Embryonic Stem Cell Research Pros and Cons | HRFnd - June 19th, 2018
- Stem Cell Research: Is It in Danger? - September 29th, 2017
- Truth About Embryonic Stem Cells | Stem Cell Orthopedic ... - September 29th, 2017
- Embryonic Stem Cell Research Still Hasn't Cured a Single ... - September 25th, 2017
- Doubts raised about CRISPR gene-editing study in human embryos - Nature.com - September 2nd, 2017
- Study shows human stem cells restore mobility in Parkinson's monkeys - Borneo Bulletin Online - September 2nd, 2017
- Sofa Vergara's ex might finally be out of luck in his battle for custody ... - Slate Magazine (blog) - September 1st, 2017
- Young cardiac cells rejuvenate heart in animal study - The San Diego Union-Tribune - August 29th, 2017